Renal disorders are characterized by the inability of the kidneys to filter out toxins and eliminate wastes. CD BioSciences is involved in a scientific consortium that focuses on a proof-of-concept to deliver novel treatments. In this consortium, CD BioSciences scientific expertise is derived from leading researchers with a track record in developing new strategies for the treatment and prevention of kidney disease across diverse populations.
Massive Clinical Trials Experience of Renal Disease
Clinical studies in renal diseases present unique challenges. One of the biggest obstacles—identifying and recruiting patients— requires trusted, long-term relationships with sites and Key Opinion Leaders (KOLs) around the world. It also requires a team of medical, regulatory and operational experts who can drive strategy and efficiency that will accelerate your product’s development. CD BioSciences has global experience conducting trials for a variety of kidney-related diseases from early through late phase. An international network of nephrology sites and strong relationships with KOLs streamlines the development process and is increased by our experience in recruiting hard to enroll patient populations. CD BioSciences conducts trials in renal-impaired patients, including patients currently undergoing dialysis, and in patients suffering from other chronic and rare kidney diseases, listed below:
Full-Service Developments on Expertise
Our scientifically-driven approach to clinical development offers you the advantage of early and ongoing insight and guidance from therapeutic experts throughout trial design and execution. Understanding that patients often have comorbidities such as cardiovascular disease, diabetes, and obesity, our nephrology and renal disease team work in collaboration with our in-house experts in these associated diseases. Our services provide greater depth and the ability to tackle complex and challenging diseases. Thanks to our experienced professionals, we offer several services, including peptide, small molecule, DNA/RNA, biologics, diagnostic kit, and biosimilars.
This broad scope of trial services, combined with a team dedicated to your study, will ensure that you have an ideal combination of innovation and transparency to move your project toward its ultimate goals. Global experience conducting Phase I-IV renal disease clinical trials spanning adult and children populations. Moreover, cross-over medical expertise in related therapeutic areas including metabolic, cardiovascular, and autoimmune. Explore each stage of our clinical services, including data management analysis and reporting, early phase trials, proof of concept, phase IIa trials, phase III trials, and first in human.
CD BioSciences offers the preclinical and clinical expertise to help you tackle the development needs of your compounds to design effective studies and accelerate recruitment. A seasoned clinical operations staff with specific experience in conducting renal disease trials. They are skilled in general toxicology, safety pharmacology, and clinical pharmacology of a wide range of compounds. With our extensive patient database and outreach, we can help you establish proof of concept by recruiting patients across a range of urological conditions. If you want to know further details, please don't hesitate to contact us.